The Valley Desk

NCT00589706 · Interventional trial

A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas

Overall registry status Completed

Phase 2

Conditions Gliomas

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov